REPLY: The Impact of Patiromer on Heart Failure Treatment With Angiotensin Inhibitors and MRAs

被引:0
|
作者
Pitt, Bertram [1 ]
Budden, Jeffrey [2 ]
Anker, Stefan D. [3 ]
Butler, Javed [4 ]
机构
[1] Univ Michigan, Ann Arbor, MI USA
[2] CSL Vifor, Redwood City, CA USA
[3] Charite, Inst Hlth Ctr Regenerat Therapies, German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany
[4] Univ Mississippi, Jackson, MS USA
关键词
D O I
10.1016/j.jacc.2024.12.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e115 / e115
页数:1
相关论文
共 50 条
  • [21] The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice
    Missouris, CG
    MacGregor, GA
    POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (861) : 409 - 411
  • [22] ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN THE TREATMENT OF CLINICAL HEART-FAILURE
    POULEUR, H
    BASIC RESEARCH IN CARDIOLOGY, 1993, 88 : 203 - 209
  • [23] Patiromer for Hyperkalemia Management in Patients Receiving Renin-Angiotensin-Aldosterone System Inhibitors for Heart Failure (DIAMOND): Prespecified Analysis of Patients With or Without Diabetes
    Filippatos, Gerasimos
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 218 - 218
  • [24] 1-YEAR SAFETY AND EFFICACY OF PATIROMER FOR HYPERKALEMIA IN HEART FAILURE PATIENTS WITH CHRONIC KIDNEY DISEASE ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS
    Pitt, Bertram
    Bushinsky, David
    Garza, Dahlia
    Stasiv, Yuri
    Du Mond, Charles
    Berman, Lance
    Bakris, George
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A855 - A855
  • [25] Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials
    Bratsos, Sosipatros
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (01)
  • [26] Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure - Reply
    Johnson, D
    Cujec, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (07) : 1333 - 1334
  • [27] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [28] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
  • [29] Angiotensin II antagonists in the treatment of heart failure
    Israili, ZH
    CARDIOVASCULAR PHARMACOTHERAPY, 2000, : 75 - 79
  • [30] Digoxin for the treatment of heart failure - Reply
    Rathore, SS
    Krumholz, HM
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07): : 662 - 663